Canadian case questions funding.
作者信息
Spurgeon D
出版信息
BMJ. 1999 Jan 9;318(7176):77. doi: 10.1136/bmj.318.7176.77b.
Abstract
摘要
相似文献
1
Canadian case questions funding.加拿大病例问题资金。
BMJ. 1999 Jan 9;318(7176):77. doi: 10.1136/bmj.318.7176.77b.
2
Canadian whistleblower row prompts broader code of conduct.加拿大举报人事件引发更广泛的行为准则。
Nature. 1998;396(6713):715. doi: 10.1038/25431.
3
Independent review adds to controversy at Sick Kids.独立审查加剧了病童医院的争议。
CMAJ. 1999 Feb 9;160(3):386-8.
4
Canadian panel calls for review of drug-trial confidentiality agreements.加拿大专家组呼吁对药物试验保密协议进行审查。
Lancet. 1998;352(9145):1996. doi: 10.1016/S0140-6736(05)61348-7.
5
Trials sponsored by drug companies: review ordered.制药公司赞助的试验：下令进行审查。
BMJ. 1998 Sep 5;317(7159):618. doi: 10.1136/bmj.317.7159.618.
6
Controversial HSC clinical trials report made public. Hospital for Sick Children.有争议的造血干细胞临床试验报告公开。病童医院。
Nat Med. 1999 Jan;5(1):7. doi: 10.1038/4676.
7
Constraints of interest: lessons at the Hospital for Sick Children.关注的限制因素：病童医院的经验教训
CMAJ. 1998 Oct 20;159(8):955-7.
8
The Olivieri debacle: where were the heroes of bioethics?奥利维耶里事件：生物伦理学的英雄们何在？
J Med Ethics. 2004 Feb;30(1):44-9; discussion 50-2. doi: 10.1136/jme.2003.005330.
9
Legal issues surrounding privately funded research cause furore in Toronto.围绕私人资助研究的法律问题在多伦多引发了轩然大波。
CMAJ. 1998 Oct 20;159(8):983-6.
10
New rules will force doctors to disclose ties to drug industry.
N Y Times Web. 1998 Feb 3:A12.
Zotero 插件